The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Keese Kyle since year 2005.
The trader's CIK number is 1380186.
At the time of this reporting, Keese Kyle is the SVP, Corporate Affairs of
Emergent Biosolutions Inc.
(stock ticker symbol EBS).
Stock purchases, sales, and option exercises reported by Keese Kyle since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-06-28
EBS
Emergent Biosolutions Inc.
Option Exercise
1,446
2.74
3,962
2007-06-29
EBS
Emergent Biosolutions Inc.
Option Exercise
1,445
2.74
3,959
2007-06-28
EBS
Emergent Biosolutions Inc.
Sale
1,446
9.69
14,011
2007-06-29
EBS
Emergent Biosolutions Inc.
Sale
1,250
9.93
12,412
2007-06-27
EBS
Emergent Biosolutions Inc.
Sale
1,445
9.58
13,843
2007-06-26
EBS
Emergent Biosolutions Inc.
Sale
1,445
9.36
13,525
2007-06-27
EBS
Emergent Biosolutions Inc.
Option Exercise
1,445
2.74
3,959
2007-06-26
EBS
Emergent Biosolutions Inc.
Option Exercise
1,445
2.74
3,959
2007-06-22
EBS
Emergent Biosolutions Inc.
Option Exercise
1,447
2.74
3,964
2007-06-22
EBS
Emergent Biosolutions Inc.
Sale
1,300
8.90
11,570
2007-06-25
EBS
Emergent Biosolutions Inc.
Option Exercise
1,451
2.74
3,975
2007-06-25
EBS
Emergent Biosolutions Inc.
Sale
1,451
9.16
13,291
2007-06-21
EBS
Emergent Biosolutions Inc.
Option Exercise
1,447
2.74
3,964
2007-06-20
EBS
Emergent Biosolutions Inc.
Option Exercise
1,447
2.74
3,964
2007-06-21
EBS
Emergent Biosolutions Inc.
Sale
1,316
9.00
11,844
2007-06-20
EBS
Emergent Biosolutions Inc.
Sale
1,336
9.37
12,518
2007-06-18
EBS
Emergent Biosolutions Inc.
Sale
1,405
10.07
14,148
2007-06-18
EBS
Emergent Biosolutions Inc.
Option Exercise
1,447
2.74
3,964
2007-06-19
EBS
Emergent Biosolutions Inc.
Option Exercise
1,447
2.74
3,964
2007-06-19
EBS
Emergent Biosolutions Inc.
Sale
1,405
9.83
13,811
2007-06-14
EBS
Emergent Biosolutions Inc.
Option Exercise
1,427
2.74
3,909
2007-06-15
EBS
Emergent Biosolutions Inc.
Option Exercise
1,447
2.74
3,964
2007-06-14
EBS
Emergent Biosolutions Inc.
Sale
1,427
8.55
12,200
2007-06-15
EBS
Emergent Biosolutions Inc.
Sale
1,405
9.39
13,192
2007-06-12
EBS
Emergent Biosolutions Inc.
Option Exercise
1,736
2.74
4,756
2007-06-13
EBS
Emergent Biosolutions Inc.
Option Exercise
4,219
2.74
11,560
2007-06-12
EBS
Emergent Biosolutions Inc.
Sale
1,545
8.73
13,487
2007-06-13
EBS
Emergent Biosolutions Inc.
Sale
3,124
8.51
26,585
2007-06-08
EBS
Emergent Biosolutions Inc.
Option Exercise
1,930
2.74
5,288
2007-06-11
EBS
Emergent Biosolutions Inc.
Option Exercise
1,930
2.74
5,288
2007-06-11
EBS
Emergent Biosolutions Inc.
Sale
1,545
8.77
13,549
2007-06-08
EBS
Emergent Biosolutions Inc.
Sale
1,545
8.46
13,070
2007-06-06
EBS
Emergent Biosolutions Inc.
Sale
1,529
9.10
13,913
2007-06-07
EBS
Emergent Biosolutions Inc.
Option Exercise
1,911
2.47
4,720
2007-06-06
EBS
Emergent Biosolutions Inc.
Option Exercise
2,083
2.47
5,145
2007-06-07
EBS
Emergent Biosolutions Inc.
Sale
1,529
8.76
13,394
2007-06-04
EBS
Emergent Biosolutions Inc.
Option Exercise
1,959
2.74
5,367
2007-06-05
EBS
Emergent Biosolutions Inc.
Sale
1,438
9.41
13,531
2007-06-04
EBS
Emergent Biosolutions Inc.
Sale
1,438
9.81
14,106
2007-06-05
EBS
Emergent Biosolutions Inc.
Option Exercise
1,959
2.74
5,367
2007-06-01
EBS
Emergent Biosolutions Inc.
Option Exercise
1,959
2.74
5,367
2007-06-01
EBS
Emergent Biosolutions Inc.
Sale
1,438
10.04
14,437
2007-05-31
EBS
Emergent Biosolutions Inc.
Sale
1,438
10.15
14,595
2007-05-31
EBS
Emergent Biosolutions Inc.
Option Exercise
1,959
2.74
5,367
2007-05-30
EBS
Emergent Biosolutions Inc.
Sale
1,320
10.16
13,411
2007-05-29
EBS
Emergent Biosolutions Inc.
Option Exercise
2,372
2.74
6,499
2007-05-30
EBS
Emergent Biosolutions Inc.
Option Exercise
1,798
2.74
4,926
2007-05-29
EBS
Emergent Biosolutions Inc.
Sale
1,320
10.72
14,150
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Keese Kyle
(SVP, Corporate Affairs of Emergent Biosolutions Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
